EAM Investors’s PLx Pharma PLXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-371,965
Closed -$7.18M – 404
2021
Q3
$7.18M Buy
371,965
+95,250
+34% +$1.66M 1.21% 2
2021
Q2
$3.82M Buy
+276,715
New +$3.28M 0.59% 26

Other funds holding PLXP

EAM Investors's PLXP Position: Q4 2021 in Review

EAM Investors sold out of PLx Pharma (PLXP) in Q4 2021, closing a stake of 371,965 shares — an estimated $7.18M sold.

EAM Investors first reported a position in PLXP in Q2 2021 and held it in 2 quarters. The position peaked at $7.18M in Q3 2021. 57 funds tracked by Wall St. Rank hold PLXP as of Q4 2021.

  • EAM Investors reported no remaining PLx Pharma position as of Q4 2021 after selling out during the quarter.
  • EAM Investors sold 371,965 PLx Pharma shares in Q4 2021, an estimated $7.18M.
  • EAM Investors first reported a position in PLx Pharma in Q2 2021 and held it in 2 quarters.
  • EAM Investors's PLx Pharma position peaked at $7.18M in Q3 2021.
  • 57 funds tracked by Wall St. Rank held PLx Pharma as of Q4 2021.

Based on EAM Investors's 13F filing for Q4 2021, filed 11 Feb 2022.